BTBR Ob/Ob mutant mice model progressive diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 21, Issue 9, 2010, Pages 1533-1542

  Hudkins, Kelly L ^a   Pichaiwong, Warangkana ^a   Wietecha, Tomasz ^a   Kowalewska, Jolanta ^a   Banas, Miriam C ^a,c   Spencer, Min W ^a   Mühlfeld, Anja ^a,d   Koelling, Mariko ^a   Pippin, Jeffrey W ^b   Shankland, Stuart J ^b   Askari, Bardia ^a   Rabaglia, Mary E ^e   Keller, Mark P ^e   Attie, Alan D ^e   Alpers, Charles E ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; GALECTIN 3;

ADOLESCENT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HYALINE DEGENERATION; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; ANIMAL; C57BL MOUSE; DIABETIC NEPHROPATHIES; DISEASE COURSE; DISEASE MODEL; FIBROSIS; KIDNEY; MOUSE MUTANT; PATHOLOGY;

ANIMALS; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; FIBROSIS; GALECTIN 3; INSULIN RESISTANCE; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; PODOCYTES;

EID: 77956528157     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009121290     Document Type: Article

References (41)

1. US Renal Data System: USRDS 2004 Annual Data Report, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004
2. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[Suppl 1]: S1-S266, 2002
3. Mohanram A, Toto RD: Outcome studies in diabetic nephropathy. Semin Nephrol 23: 255-271, 2003
4. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA 290: 1884-1890, 2003
5. Breyer MD, Bottinger E, Brosius FC, Coffman TM, Fogo A, Harris RC, Heilig CW, Sharma K: Diabetic nephropathy: Of mice and men. Adv Chronic Kidney Dis 12: 128-145, 2005
6. Breyer MD, Bottinger E, Brosius FC 3rd, Coffman TM, Harris RC, Heilig CW, Sharma K: Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45, 2005
7. Brosius FC 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, Gurley SB, Harris RC, Kakoki M, Kretzler M, Leiter EH, Levi M, McIndoe RA, Sharma K, Smithies O, Susztak K, Takahashi N, Takahashi T: Mouse models of diabetic nephropathy. J AmSoc Nephrol 20: 2503-2512, 2009
8. Janssen U, Phillips AO, Floege J: Rodent models of nephropathy associated with type II diabetes. J Nephrol 12: 159-172, 1999 (Pubitemid 29370823)
9. Tesch GH, Nikolic-Paterson DJ: Recent insights into experimental mouse models of diabetic nephropathy. Nephron Exp Nephrol 104: e57-e62, 2006
10. Jefferson JA, Shankland SJ, Pichler RH: Proteinuria in diabetic kidney disease: A mechanistic viewpoint. Kidney Int 74: 22-36, 2008 (Pubitemid 351841893)
11. Clee SM, Nadler ST, Attie AD: Genetic and genomic studies of the BTBR ob/ob mouse model of type 2 diabetes. Am J Ther 12: 491-498, 2005
12. Ranheim T, Dumke C, Schueler KL, Cartee GD, Attie AD: Interaction between BTBR and C57BL/6J genomes produces an insulin resistance syndrome in (BTBR x C57BL/6J) F1 mice. Arterioscler Thromb Vasc Biol 17: 3286-3293, 1997 (Pubitemid 28016090)
13. Clee SM, Attie AD: The genetic landscape of type 2 diabetes in mice. Endocr Rev 28: 48-83, 2007 (Pubitemid 46220850)
14. Stoehr JP, Byers JE, Clee SM, Lan H, Boronenkov IV, Schueler KL, Yandell BS, Attie AD: Identification of major quantitative trait loci controlling body weight variation in ob/ob mice. Diabetes 53: 245-249, 2004 (Pubitemid 38044723)
15. Stoehr JP, Nadler ST, Schueler KL, Rabaglia ME, Yandell BS, Metz SA, Attie AD: Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci. Diabetes 49: 1946-1954, 2000
16. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K: Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 105: 1243-1252, 2000 (Pubitemid 30266077)
17. Burgueno AL, Landa MS, Schuman ML, Alvarez AL, Carabelli J, Garcia SI, Pirola CJ: Association between diencephalic thyroliberin and arterial blood pressure in agouti-yellow and ob/ob mice may be mediated by leptin. Metabolism 56: 1439-1443, 2007 (Pubitemid 47411579)
18. Clee SM, Yandell BS, Schueler KM, Rabaglia ME, Richards OC, Raines SM, Kabara EA, Klass DM, Mui ET, Stapleton DS, Gray-Keller MP, Young MB, Stoehr JP, Lan H, Boronenkov I, Raess PW, Flowers MT, Attie AD: Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus. Nat Genet 38: 688-693, 2006 (Pubitemid 43927312)
19. Goodarzi MO, Lehman DM, Taylor KD, Guo X, Cui J, Quinones MJ, Clee SM, Yandell BS, Blangero J, Hsueh WA, Attie AD, Stern MP, Rotter JI: SORCS1: A novel human type 2 diabetes susceptibility gene suggested by the mouse. Diabetes 56: 1922-1929, 2007
20. Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B: Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 18: 539-550, 2007 (Pubitemid 46193319)
21. Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC: Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 17:2664-2669, 2006 (Pubitemid 44484656)
22. Kosugi T, Heinig M, Nakayama T, Connor T, Yuzawa Y, Li Q, Hauswirth WW, Grant MB, Croker BP, Campbell-Thompson M, Zhang L, Atkinson MA, Segal MS, Nakagawa T: Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice. Am J Pathol 174: 1221-1229, 2009
23. Keller MP, Choi Y, Wang P, Davis DB, Rabaglia ME, Oler AT, Stapleton DS, Argmann C, Schueler KL, Edwards S, Steinberg HA, Chaibub Neto E, Kleinhanz R, Turner S, Hellerstein MK, Schadt EE, Yandell BS, Kendziorski C, Attie AD: A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome Res 18: 706-716, 2008 (Pubitemid 351645061)
24. Paterson AD, Waggott D, Boright AP, Hosseini SM, Shen E, Sylvestre MP, Wong I, Bharaj B, Cleary PA, Lachin JM, Below JE, Nicolae D, Cox NJ, Canty AJ, Sun L, Bull SB: A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both HbA1c and glucose. Diabetes 59: 539-549, 2010
25. Enriori PJ, Evans AE, Sinnayah P, Cowley MA: Leptin resistance and obesity. Obesity (Silver Spring) 14[Suppl 5]: 254S-258S, 2006
26. O'Brien K, Kim J, Wietecha T, Hudkins K, McDonald T, Minami E, Alpers C: A new murine model of diabetic cardiomyopathy: The female leptin-deficient, black and tan brachyuric mouse. Circulation 120: S490, 2009
27. Whitesall SE, Hoff JB, Vollmer AP, D'Alecy LG: Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods. Am J Physiol Heart Circ Physiol 286: H2408-H2415, 2004
28. Feng M, Whitesall S, Zhang Y, Beibel M, D'Alecy L, DiPetrillo K: Validation of volume-pressure recording tail-cuff blood pressure measurements. Am J Hypertens 21: 1288-1291, 2008
29. Guo S, Kowalewska J, Wietecha TA, Iyoda M, Wang L, Yi K, Spencer M, Banas M, Alexandrescu S, Hudkins KL, Alpers CE: Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis. J Am Soc Nephrol 19: 1168-1176, 2008
30. Taneda S, Hudkins KL, Cui Y, Farr AG, Alpers CE, Segerer S: Growth factor expression in a murine model of cryoglobulinemia. Kidney Int 63: 576-590, 2003 (Pubitemid 36126803)
31. Alpers CE, Seifert RA, Hudkins KL, Johnson RJ, Bowen-Pope DF: Developmental patterns of PDGF B-chain, PDGF-receptor, and alphaactin expression in human glomerulogenesis. Kidney Int 42: 390-399, 1992
32. Rosenberg I, Cherayil BJ, Isselbacher KJ, Pillai S: Mac-2-binding glycoproteins: Putative ligands for a cytosolic beta-galactoside lectin. J Biol Chem 266: 18731-18736, 1991 (Pubitemid 21908145)
33. Taneda S, Segerer S, Hudkins KL, Cui Y, Wen M, Segerer M, Wener MH, Khairallah CG, Farr AG, Alpers CE: Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 159: 2355-2369, 2001 (Pubitemid 33104288)
34. Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG, Alpers CE: Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol 14: 968-980, 2003 (Pubitemid 36359278)
35. Weibel ER: Practical Methods for Biological Morphometry, London, Academic Press, 1979, pp 40-116
36. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99: 342-348, 1997 (Pubitemid 27053474)
37. Steffes MW, Schmidt D, McCrery R, Basgen JM: Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59: 2104-2113, 2001 (Pubitemid 32467602)
38. Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, Conti S, Kawachi H, Hill P, Remuzzi G, Remuzzi A: Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol 168: 42-54, 2006 (Pubitemid 43062558)
39. White KE, Bilous RW: Estimation of podocyte number: A comparison of methods. Kidney Int 66: 663-667, 2004 (Pubitemid 38982009)
40. Sanden SK, Wiggins JE, Goyal M, Riggs LK, Wiggins RC: Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms' tumor-1 protein used as a podocyte nuclear marker. J Am Soc Nephrol 14: 2484-2493, 2003 (Pubitemid 37169334)
41. Siu B, Saha J, Smoyer WE, Sullivan KA, Brosius, FC 3rd: Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: Prevention by lipoic acid treatment. BMC Nephrol 7: 6, 2006